Why Is Intuitive Surgical (ISRG) Up 7.1% Since Last Earnings Report?
Werte in diesem Artikel
It has been about a month since the last earnings report for Intuitive Surgical, Inc. (ISRG). Shares have added about 7.1% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Intuitive Surgical due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Intuitive Surgical, Inc. before we dive into how investors and analysts have reacted as of late.ISRG Q3 Earnings & Revenue Beat, Gross Margin DeclinesIntuitive Surgical reported third-quarter 2025 adjusted earnings per share of $2.40, which beat the Zacks Consensus Estimate of $1.99 by 20.6%. The bottom line improved 30.4% year over year.GAAP earnings per share in the quarter was $1.95, up 25% from the year-ago quarter’s level.Revenue DetailsThe company reported revenues of $2.51 billion, up 23% year over year, as well as at constant currency (cc). A higher number of installed systems and growth in the da Vinci procedure volume contributed to the improvement. The top line beat the Zacks Consensus Estimate by 3.9%.Segmental DetailsInstruments & AccessoriesRevenues from this segment totaled $1.52 billion, indicating a year-over-year improvement of 20.1%. This can be attributed to the da Vinci procedure’s 19% volume growth. The sales growth also reflects approximately 52% growth in Ion procedures and 91% for the SP platform. The top-line improvement was also aided by higher system utilization, partially offset by a lower mix of bariatric procedures and a higher mix of cholecystectomy procedures.SystemsThis segment’s revenues totaled $590.4 million, up 32.7% year over year. The robust growth was driven by a higher system placement and a rise in average selling price. Intuitive Surgical shipped 427 da Vinci Surgical Systems compared with 379 in the prior-year quarter. The company placed 263 systems in the United States and 164 in international markets. During the third quarter, ISRG placed 240 of its latest da Vinci 5 systems compared with 180 during the second quarter of 2025.ServicesRevenues from this segment amounted to $395.9 million, up 20.4% from the year-ago quarter’s level.MarginsAdjusted gross profit was $1.70 billion, up 21% year over year. As a percentage of revenues, the gross margin was 68%, down approximately 110 bps from the prior-year quarter’s figure.Selling, general and administrative expenses totaled $573.3 million, up 12.3% year over year.Research and development expenses totaled $329.4 million, up 15.2% on a year-over-year basis.Adjusted operating income totaled $975.9 million, up 29.2% year over year. As a percentage of revenues, the operating margin was 38.9%, up approximately 190 bps from the prior-year quarter’s figure.Financial PositionIntuitive Surgical exited the third quarter with cash, cash equivalents and investments of $8.43 billion compared with $9.53 billion in the previous quarter.How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates review.The consensus estimate has shifted 5.03% due to these changes.VGM ScoresCurrently, Intuitive Surgical has a average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Following the exact same course, the stock has a grade of D on the value side, putting it in the bottom 40% for value investors.Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Intuitive Surgical has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Intuitive Surgical und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Intuitive Surgical
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Intuitive Surgical Inc
Analysen zu Intuitive Surgical Inc
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
| 22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
| 02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
| 19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
| 18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
| 22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
| 02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
| 19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
| 18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.01.2018 | Intuitive Surgical Hold | Canaccord Adams | |
| 18.07.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets | |
| 30.06.2017 | Intuitive Surgical Neutral | Cantor Fitzgerald | |
| 30.05.2017 | Intuitive Surgical Hold | Canaccord Adams | |
| 17.04.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.01.2015 | Intuitive Surgical Sell | CRT Capital | |
| 22.10.2014 | Intuitive Surgical Sell | CRT Capital | |
| 09.01.2009 | Intuitive Surgical Downgrade | Brean Murray, Carret & Co., LLC | |
| 26.08.2005 | Update Intuitive Surgical Inc. : Underperform | Jefferies & Co |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen